Massachusetts Non-Local Sources MA

Biogen Alzheimer's drug gets U.S. FDA staff's backing ahead approval meeting

Nov 4, 2020

Nov 4 (Reuters) - Biogen Inc's experimental Alzheimer's disease drug was found effective enough in a large trial to support approval, U.S. Food and Drug...

Read the full story at

Biogen Alzheimer's drug gets U.S. FDA staff's backing ahead approval meeting

More from Massachusetts Non-Local Sources

Clancy Trial's Holdout Juror Says That the Defendant Was 'Methodical'

5 Bike Ride Trails in the U.S. That You'll Really Love

The Controversial Class That M.I.T. Is Paying a Professor Not to Teach

Massachusetts Man Pleads Guilty to Selling Plutonium From Russia

These Birds Are Louder Than Elephants, Jackhammers and Chain Saws

A Show Gives a Taste of What a U.S. Pavilion in Venice Might Have Been

A 'Family Disease' Stalked the Sedgwicks. He Hoped to Escape It.

Judge in Lindsay Clancy's Case Declines to Find Her Not Guilty After Mistrial

Biogen Alzheimer&#39;s drug gets U.S. FDA staff&#39;s backing ahead approval meeting

More from Massachusetts Non-Local Sources

Biogen Alzheimer's drug gets U.S. FDA staff's backing ahead approval meeting